News

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...
Once thought to be a condition affecting only older men, erectile dysfunction is increasingly impacting men in their 20s and ...
When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.